The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
Interest in the role of coagulation and fibrinolysis in the nervous system was active in several laboratories dating back before cloning of the functional thrombin receptor in 1991. As one of those, our attention was initially on thrombin and plasminogen activators in synapse formation and eliminati...
Main Authors: | Barry W. Festoff, Chris Dockendorff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/11/1558 |
Similar Items
-
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
by: Phillip LR. Nicolson, et al.
Published: (2020-07-01) -
Platelet <i>Versus</i> Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
by: Cédric Garcia, et al.
Published: (2022-04-01) -
Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022-11-01) -
Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
by: Julia S. Gauer, et al.
Published: (2022-10-01) -
COVID-19 and renal involvement; evolving role of thromboinflammation, vascular and glomerular disease in the pathogenesis
by: Tella Sadighpour, et al.
Published: (2021-07-01)